[Experimental study of effect of epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in combination with irinotecan]. [electronic resource]
Producer: 20080214Description: 578-82 p. digitalISSN:- 0253-3766
- Antineoplastic Agents -- pharmacology
- Antineoplastic Agents, Phytogenic -- pharmacology
- Apoptosis -- drug effects
- Camptothecin -- analogs & derivatives
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Survival -- drug effects
- Colonic Neoplasms -- enzymology
- DNA Topoisomerases, Type I -- metabolism
- Drug Synergism
- ErbB Receptors -- antagonists & inhibitors
- Gefitinib
- HT29 Cells
- Humans
- Inhibitory Concentration 50
- Irinotecan
- Mitogen-Activated Protein Kinase Kinases -- metabolism
- Phosphorylation -- drug effects
- Proto-Oncogene Proteins c-akt -- metabolism
- Quinazolines -- pharmacology
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.